Huaren Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.061x

Huaren Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Huaren Pharmaceutical Co Ltd (300110) has a cash flow conversion efficiency ratio of 0.061x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥86.78 Million ≈ $12.70 Million USD) by net assets (CN¥1.43 Billion ≈ $208.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Huaren Pharmaceutical Co Ltd (2007–2025)

Cash flow conversion efficiency of Huaren Pharmaceutical Co Ltd from 2007 to 2025. This chart illustrates how Huaren Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 300110 stock price and chart for real-time trading data and today's change.

Huaren Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Huaren Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Huaren Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Huaren Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see Huaren Pharmaceutical Co Ltd (300110) market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Hudson Pacific Properties Inc NYSE:HPP	0.010x
Propert & Buil TA:PTBL	0.009x
CapitaLand Malaysia Mall Trust KLSE:5180	0.021x
Orient Electric Limited NSE:ORIENTELEC	-0.055x
TFE Co. Ltd. KQ:425420	0.015x
Electrosteel Castings Limited NSE:ELECTCAST	0.070x
Anhui Xinli Finance Co Ltd SHG:600318	0.060x
Eastern & Oriental Bhd KLSE:3417	-0.010x

Annual Cash Flow Conversion Efficiency for Huaren Pharmaceutical Co Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Huaren Pharmaceutical Co Ltd from 2007 to 2025. Review 300110 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥909.06 Million ≈ $133.02 Million	CN¥390.23 Million ≈ $57.10 Million	0.429x	+82.96%
2024-12-31	CN¥1.37 Billion ≈ $201.05 Million	CN¥322.36 Million ≈ $47.17 Million	0.235x	+112.36%
2023-12-31	CN¥2.77 Billion ≈ $404.75 Million	CN¥305.60 Million ≈ $44.72 Million	0.110x	+31.77%
2022-12-31	CN¥2.60 Billion ≈ $380.43 Million	CN¥217.98 Million ≈ $31.90 Million	0.084x	+135.41%
2021-12-31	CN¥2.44 Billion ≈ $357.55 Million	CN¥-578.52 Million ≈ $-84.66 Million	-0.237x	-5034.78%
2020-12-31	CN¥2.33 Billion ≈ $340.88 Million	CN¥-10.74 Million ≈ $-1.57 Million	-0.005x	-103.35%
2019-12-31	CN¥2.25 Billion ≈ $329.02 Million	CN¥309.33 Million ≈ $45.26 Million	0.138x	+21.89%
2018-12-31	CN¥2.25 Billion ≈ $329.72 Million	CN¥254.32 Million ≈ $37.21 Million	0.113x	-17.22%
2017-12-31	CN¥1.55 Billion ≈ $226.55 Million	CN¥211.08 Million ≈ $30.89 Million	0.136x	+14.53%
2016-12-31	CN¥1.53 Billion ≈ $223.29 Million	CN¥181.65 Million ≈ $26.58 Million	0.119x	+813.41%
2015-12-31	CN¥1.44 Billion ≈ $210.71 Million	CN¥18.77 Million ≈ $2.75 Million	0.013x	-70.59%
2014-12-31	CN¥1.48 Billion ≈ $216.53 Million	CN¥65.56 Million ≈ $9.59 Million	0.044x	+62.55%
2013-12-31	CN¥1.46 Billion ≈ $213.55 Million	CN¥39.78 Million ≈ $5.82 Million	0.027x	-63.29%
2012-12-31	CN¥1.34 Billion ≈ $195.97 Million	CN¥99.44 Million ≈ $14.55 Million	0.074x	+48.64%
2011-12-31	CN¥1.19 Billion ≈ $174.38 Million	CN¥59.53 Million ≈ $8.71 Million	0.050x	-28.93%
2010-12-31	CN¥1.10 Billion ≈ $161.57 Million	CN¥77.61 Million ≈ $11.36 Million	0.070x	-42.90%
2009-12-31	CN¥313.80 Million ≈ $45.92 Million	CN¥38.63 Million ≈ $5.65 Million	0.123x	-52.47%
2008-12-31	CN¥221.03 Million ≈ $32.34 Million	CN¥57.24 Million ≈ $8.38 Million	0.259x	+524.40%
2007-12-31	CN¥184.68 Million ≈ $27.02 Million	CN¥7.66 Million ≈ $1.12 Million	0.041x	--

About Huaren Pharmaceutical Co Ltd

SHE:300110 China Drug Manufacturers - Specialty & Generic

Market Cap

$460.17 Million

CN¥3.14 Billion CNY

Market Cap Rank

#12333 Global

#3587 in China

Share Price

CN¥2.66

Change (1 day)

-2.21%

52-Week Range

CN¥2.47 - CN¥3.95

All Time High

CN¥13.46